Altogether, our results indicate that iron insufficiency models (iron chelators, IRP2 deletion, and IDD) all attenuated intramuscular iron levels, albeit with no beneficial effect on DUX4-Tg mice, which suffered physical function deterioration. The gene discussed is DUX4; the disease is intervertebral disk degenerative disorder.